蓝丰生化
(002513)
| 流通市值：14.71亿 | | | 总市值：19.12亿 |
| 流通股本：2.89亿 | | | 总股本：3.76亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 652,131,097.94 | 2,342,107,165.64 | 1,829,738,679.83 | 1,196,198,328.15 |
| 营业总成本 | 681,677,256.14 | 2,544,994,088.32 | 1,981,009,480.56 | 1,286,810,496.18 |
| 其他经营收益 | | | | |
| 营业利润 | -31,693,629.17 | -284,112,185.83 | -138,243,368.95 | -80,436,542.56 |
| 利润总额 | -31,649,689.77 | -290,068,611.54 | -139,227,945.51 | -81,578,653.55 |
| 净利润 | -27,638,674.44 | -271,781,841.39 | -116,170,537.41 | -64,142,150.6 |
| 每股收益 | | | | |
| 其他综合收益 | - | 891,217.38 | 1,111,437.39 | 1,111,437.39 |
| 综合收益总额 | -27,638,674.44 | -270,890,624.01 | -115,059,100.02 | -63,030,713.21 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,007,741,568.58 | 2,296,834,355.56 | 2,299,187,544.75 | 1,888,237,633.85 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,052,638,300.98 | 2,180,020,651.69 | 2,343,981,085.39 | 2,119,150,372.83 |
| 资产总计 | 4,060,379,869.56 | 4,476,855,007.25 | 4,643,168,630.14 | 4,007,388,006.68 |
| 流动负债: | | | | |
| 流动负债合计 | 2,990,041,202.73 | 3,306,508,147.8 | 3,590,443,687.81 | 3,012,242,412.94 |
| 非流动负债: | | | | |
| 非流动负债合计 | 722,536,397.22 | 815,337,902.01 | 825,939,708.04 | 741,133,280.22 |
| 负债合计 | 3,712,577,599.95 | 4,121,846,049.81 | 4,416,383,395.85 | 3,753,375,693.16 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 40,089,413.67 | 43,689,201.49 | -14,130,215.98 | -6,962,262.93 |
| 股东权益合计 | 347,802,269.61 | 355,008,957.44 | 226,785,234.29 | 254,012,313.52 |
| 负债和股东权益合计 | 4,060,379,869.56 | 4,476,855,007.25 | 4,643,168,630.14 | 4,007,388,006.68 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 738,702,988.13 | 2,143,196,827.22 | 1,606,793,158.37 | 1,064,139,652.94 |
| 经营活动现金流出小计 | 688,429,153.95 | 2,519,199,482.75 | 1,856,463,257.61 | 1,198,854,597.49 |
| 经营活动产生的现金流量净额 | 50,273,834.18 | -376,002,655.53 | -249,670,099.24 | -134,714,944.55 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 909,047.25 | 101,397,423.86 | 3,019,257.69 | 559,078.38 |
| 投资活动现金流出小计 | 6,049,252.32 | 145,912,113.36 | 82,528,112.87 | 66,618,284.84 |
| 投资活动产生的现金流量净额 | -5,140,205.07 | -44,514,689.5 | -79,508,855.18 | -66,059,206.46 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 109,465,866.39 | 1,065,818,308.35 | 1,190,326,291.68 | 608,254,248.97 |
| 筹资活动现金流出小计 | 125,344,694.31 | 673,897,904.75 | 896,140,563.87 | 441,037,779.04 |
| 筹资活动产生的现金流量净额 | -15,878,827.92 | 391,920,403.6 | 294,185,727.81 | 167,216,469.93 |
| 汇率变动对现金及现金等价物的影响 | -1,754,804.26 | 986,366.32 | 3,488,617.06 | 3,404,845.83 |
| 现金及现金等价物净增加额 | 27,499,996.93 | -27,610,575.11 | -31,504,609.55 | -30,152,835.25 |
| 期末现金及现金等价物余额 | 65,176,897.89 | 37,676,900.96 | 33,782,866.52 | 35,134,640.82 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -27,610,575.11 | - | -30,152,835.25 |